A first case report of clinical response to targeted therapy in a patient with primary myoepithelial carcinoma of the lung harboring EGFR exon 19 deletion

@article{Xie2020AFC,
  title={A first case report of clinical response to targeted therapy in a patient with primary myoepithelial carcinoma of the lung harboring EGFR exon 19 deletion},
  author={Xiao-hong Xie and X. Lin and M. Liu and Y. Qin and M. Ouyang and S. Li and Y. Gu and Shuyin Chen and J. Xiang and Chengzhi Zhou},
  journal={Diagnostic Pathology},
  year={2020},
  volume={15}
}
  • Xiao-hong Xie, X. Lin, +7 authors Chengzhi Zhou
  • Published 2020
  • Medicine
  • Diagnostic Pathology
  • Background Primary myoepithelial carcinoma of the lung is a rare subtype in lung cancer. Comprehensive molecular profiling of myoepithelial carcinoma of the lung is absent, neither was clinical evidence of targeted therapy available for this disease. Therefore, the optimal treatment regimen of this tumor needs to be established. Case presentation Here we present a case of a 68-year-old patient with stage IVB primary myoepithelial carcinoma of the lung who harbored EGFR exon 19 deletion and KRAS… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 14 REFERENCES
    Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapy
    1
    Epithelial-myoepthelial carcinoma of the tracheobronchial tree: the prognostic role of myoepithelial cells.
    16
    Myoepithelial carcinoma of the lung arising from bronchial submucosa.
    51
    Myoepithelioma: definitions and diagnostic criteria.
    127